On 2025-05-01, Tarsus Pharmaceuticals, Inc. (TARS) announced earnings per share of $-0.64 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.69.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.40 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-01 | 2025-03-31 | $-0.69 | $-0.64 |
| 2025-02-25 | 2024-12-31 | $-0.68 | $-0.60 |
| 2024-11-13 | 2024-09-30 | $-0.90 | $-0.61 |
| 2024-08-08 | 2024-06-30 | $-0.98 | $-0.88 |
| 2024-05-08 | 2024-03-31 | $-1.15 | $-1.01 |
| 2024-02-27 | 2023-12-31 | $-1.37 | $-1.31 |
| 2023-11-09 | 2023-09-30 | $-1.40 | $-1.28 |
| 2023-08-10 | 2023-06-30 | $-1.08 | $-1.17 |
| 2023-05-09 | 2023-03-31 | $-0.95 | $-0.88 |
| 2023-03-13 | 2022-12-31 | $-0.97 | $-0.49 |
| 2022-11-09 | 2022-09-30 | $-0.98 | $-0.84 |
| 2022-08-11 | 2022-06-30 | $-0.65 | $-0.24 |
| 2022-05-10 | 2022-03-31 | $-0.87 | $-0.98 |
| 2022-03-14 | 2021-12-31 | $-0.77 | $-0.72 |
| 2021-11-09 | 2021-09-30 | $-0.65 | $-0.76 |
| 2021-08-04 | 2021-06-30 | $-0.44 | $0.29 |
| 2021-05-11 | 2021-03-31 | $-0.64 | $0.47 |